Latest news

Wrestlers' protest | Minor grappler's father makes a U-Turn, case against BrijBhushan Singh weakens

Wrestlers' protest | Minor grappler's father makes a U-Turn, case against BrijBhushan Singh weakens

'Girls used to deliver before turning 17': Gujarat HC on 16-year-old rape survivor's abortion plea

'Girls used to deliver before turning 17': Gujarat HC on 16-year-old rape survivor's abortion plea

'With great power...': Delhi court while convicting cop for taking bribes

'With great power...': Delhi court while convicting cop for taking bribes

WTC final 2023, IND vs AUS: Team India in trouble, end Day 2 at 151/5

WTC final 2023, IND vs AUS: Team India in trouble, end Day 2 at 151/5

Fake admission scam: Canadian panel asks authorities to stop deportation of Indian students

Fake admission scam: Canadian panel asks authorities to stop deportation of Indian students

New immunotherapy drug gives hope for prostate cancer

Updated: Sep 02, 2022 10:53

|

Editorji News Desk

whatsapp | editorji

facebook | editorji

twitter | editorji

email | editorji

telegram | editorji

share | editorji

Patients suffering from terminal prostate cancer could get 'two more years of life' with a new experimental immunotherapy drug tested by researchers at The Institute of Cancer Research, London. 258 patients who had exhausted all treatment options were studied and were administered the IV drug pembrolizumab. 20 patients saw their tumour disappear or shrink. Immunotherapy has worked for cancers such as melanomas.

Up Next

New immunotherapy drug gives hope for prostate cancer

New immunotherapy drug gives hope for prostate cancer

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.